Table 1 Baseline characteristics of study patients
variable | Total population N = 142 | Type D personality N = 37 | Non-Type D personality N = 105 |
|---|---|---|---|
Age ± SD | 67 ± 14 | 64 ± 13 | 67 ± 14 |
Male n (%) | 90 (63) | 24(64) | 66(62) |
Surgical procedure n (%) | |||
 CABG | 26 (18) | 7 (18) | 19 (18) |
 CABG+Valve surgery | 10 (7) | 2 (5) | 8 (7) |
 Valve surgery | 65 (45) | 14 (37) | 51 (48) |
 Thoracic blood vessel replacement | 7 (4) | 3 (8) | 4 (3) |
 Thoracic blood vessel replacement+VALVE surgery | 6 (4) | 1 (2) | 5 (4) |
 Abdominal blood vessel replacement | 5 (3) | 1 (2) | 4 (3) |
 Endovascular aortic repair | 16 (11) | 5 (13) | 11 (10) |
 ASD/VSD closer | 2 (1) | 1 (2) | 1 (1) |
 Heart tumor resection | 3 (2) | 2 (5) | 1 (1) |
 Ventricular aneurysm resection | 2 (1) | 1 (2) | 1 (1) |
 MMSE ± SD | 28 ± 1.52 | 28 ± 1.50 | 28 ± 1.53 |
Depressive symptom a ± SD | 1.9 ± 2.7 | 3.0 ± 2.9 | 1.6 ± 2.5 |
DS 14 | |||
 Negative Affectivity (NA) | 6.6 ± 6.0 | 14.8 ± 4.2 | 3.7 ± 3.2 |
 Social Inhibition (SI) | 8.7 ± 6.6 | 16.0 ± 4.7 | 6.2 ± 5.1 |
 EuroSCOREII ± SD | 2.0 ± 2.0 | 1.7 ± 1.5 | 2.1 ± 2.1 |
 Aortic clamping times, min (IQR) | 135 (0, 206) | 136 (34, 214) | 135 (0, 208) |
 mSOFA b ± SD | 3.5 ± 2.1 | 3.4 ± 1.9 | 3.5 ± 2.2 |
 Benzodiazepine (mg/kg/day) b ± SD | 0.06 ± 0.5 | 0.06 ± 0.41 | 0.06 ± 0.53 |
 Propofol (mg/kg/day) b ± SD | 2.8 ± 6.6 | 3.0 ± 7.3 | 2.3 ± 4.1 |
 Dexmedetomidine (μg/kg/day) b ± SD | 0.8 ± 3.0 | 0.6 ± 1.2 | 0.9 ± 3.4 |
 Prevalence of delirium n (%) | 49 (34) | 17 (45) | 32 (30) |
 Delirium/coma days ± SD | 1.5 ± 1.7 | 2.1 ± 1.9 | 1.3 ± 1.6 |
 Coma days ± SD | 0.9 ± 1.1 | 0.9 ± 1.0 | 0.8 ± 1.1 |
 Delirium days ± SD | 0.6 ± 1.0 | 1.1 ± 1.5 | 0.4 ± 0.8 |